target directory

oxi4503 combretastatin a1 diphosphate targets the tumor vasculature by disrupting the microtubule network clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.